Back in December 2001, Mike Collette faced a grim reality when his CFO informed him that PatientPoint was merely three weeks away from insolvency. During those tense holiday weeks, Collette found himself watching It’s A Wonderful Life, struck by the sobering realization that his professional circumstances mirrored George Bailey's struggles. Salvation arrived just in time when a client expedited a $250,000 invoice, securing payroll and keeping the enterprise afloat. Yet, this was only one of many dramatic turns in Collette's entrepreneurial journey.

His venture originally launched as OnTarget Media, born from the financial gamble of maxing out a life insurance policy and a credit card. Over time, Collette transformed the enterprise into a cutting-edge digital point-of-care network, riding the convergence of pharmaceutical advertising, emerging flat-screen technology, and the nascent internet. Along the way, he navigated four distinct private equity acquisitions, faced ouster from the very company he built, and ultimately returned to acquire Outcome Health—a fierce competitor that had once threatened to brand him an unsuccessful chief executive. Today, PatientPoint spans approximately 35,000 medical locations nationwide. Now, Collette is channeling that hard-earned resilience into a brand-new arena: the ultra-premium spirits market with Double Cross Vodka.

Financing a Vision With Personal Risk

Reflecting on the grueling beginnings, Collette acknowledges the extreme risks he took. Leaving Procter & General before mapping out his exact next steps, he plunged headfirst into place-based media during an era dominated by just four primary channels: television, radio, print, and outdoor. Initial campaigns targeted high-impact spaces, such as maternity wards for Pampers and gastrointestinal offices for Metamucil. Recognizing that physicians loathed trekking to supply closets for patient education materials, Collette pioneered the concept of placing these vital resources directly inside exam rooms, drastically improving workflow and patient comprehension across specialties like dentistry, dermatology, and primary care.

Initial business models, however, proved precarious. Operating in the late 1980s without accessible venture capital in Cincinnati, the company relied on custom build-out fees funded upfront by clients. Unfortunately, clients eventually realized they could reclaim ownership of the networks once contracts expired, slashing profit margins by up to 90 percent. This forcing function compelled Collette to pivot toward a true media model, retaining ownership and absorbing the financial risk of network expansion ourselves.

The Digital Revolution and the Three-Week Crisis

The dawn of the year 2000 brought a monumental technological convergence: the rise of internet-connected displays, the legalization of direct-to-consumer pharmaceutical marketing, and the advent of LCD flat screens. Seizing the moment, Collette expanded from waiting rooms into exam rooms, and eventually introduced a physician-focused channel featuring medical insights blended with lighter entertainment content. Financial backing from radio entrepreneur and mentor Frank Wood provided the crucial runway needed to scale.

Yet, stability remained elusive. In 2001, just prior to securing vital funding, the company hit a wall. Collette recalls his CFO warning him of total financial depletion in precisely three weeks—a crisis mirrored by the bleak holiday mood of It’s A Wonderful Life. Fortunately, an early client payment of $250,000 covered payroll obligations, bridging the gap until Frank Wood’s investment arrived in 2002 to fuel the digital transformation.

Navigating Private Equity, Ouster, and Redemption

As revenues climbed from $8 million to $20 million with robust EBITDA, private equity entered the picture. Collette ultimately sold stakes across four successive private equity partnerships, including L Catterton and Advent, leveraging institutional capital to aggressively scale physical screen infrastructure.

Despite this hyper-growth, shifting pharmaceutical patent cliffs in 2012 abruptly erased a third of revenues and half of profits. Pressured by investors who brought in a digitally focused successor, Collette was effectively nudged out of leadership into a chairman role. Predictably, under new leadership, the company accumulated massive debt while a formidable competitor, Outcome Health, surged forward with half a billion dollars in venture backing.

Returning to the helm three and a half years later amid covenant defaults and hostile lenders, Collette orchestrated a daring $140 million financing package to double down on network expansion. Months later, explosive revelations surfaced regarding Outcome Health fabricating its network metrics, a scandal that eventually led to criminal convictions for its leadership and paved the way for PatientPoint's triumphant acquisition of its former rival.

Building an Unassailable Regulatory Moat

Navigating strict healthcare regulations prevented competitors from simply buying their way into the market. Because direct payments to physicians are prohibited, PatientPoint had to earn every single healthcare location individually, establishing a deeply defensible competitive moat across 35,000 sites. Having mastered the complexities of regulated healthcare media, Collette now brings that same disciplined strategic execution to the spirits industry, applying hard-won lessons from a career defined by resilience and reinvention.